December 21, 2016
Janssen asks FDA approval for psoriatic arthritis drug
Janssen Biotech has submitted two Supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) seeking approval…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
December 21, 2016
BMS and Calithera Biosciences team up against cancer
Bristol-Myers Squibb Company and Calithera Biosciences, Inc., a clinical stage biotechnology company focused on discovering and developing novel small molecule…
December 21, 2016
Hansa Medical successfully completes Phase II IdeS study; QUITS IdeS study in acquired TTP
Hansa Medical AB has announced completion of a Phase II study entitled “A Phase II Study to Evaluate the Safety,…
December 21, 2016
Oasmia Pharmaceutical reports positive results from breast cancer drug study
Oasmia Pharmaceutical, a developer of a new generation of drugs within human and veterinary oncology, today presented positive results from…
December 21, 2016
Kiadis Pharma provides update on Phase II trial with cancer drug
Kiadis Pharma has announced an update on the second dose Phase II trial with ATIR101 (CR-AIR-008 ).
December 21, 2016
Galapagos’s study of cystic fibrosis drug shows good results
Galapagos has reported topline results from its Saphira 1 Phase 2 study in cystic fibrosis patients with potentiator GLPG1837.
December 21, 2016
Takeda makes EUR10 million equity investment in TiGenix
Belgian based biopharmaceutical company TiGenix has exercised the option granted by Takeda under the licensing agreement to make a EUR10…
December 21, 2016
Ipsen to sell Exelixis’s cabozantinib in Canada
Exelixis and Ipsen have signed an amendment to the exclusive collaboration and licensing agreement for the commercialization and continued development…
December 21, 2016
FDA accepts Vernalis and Tris Pharma’s NDA for cough drug
U.S. Food and Drug Administration (“FDA”) has accepted Vernalis and Tris Pharma’s CCP-08 New Drug Application (“NDA”) for full review.…
December 21, 2016
Bayer and Leica Biosystems unite to fight cancer
Bayer has entered into an agreement with Leica Biosystems to collaborate on the development of companion diagnostic tests based on…